Transcatheter Treatment: Procedures and Heart Valve Market

  • ID: 4750821
  • Report
  • Region: Global
  • 164 Pages
  • BCC Research
1 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardiopolymers Inc.
  • Hormone Foundation
  • Microport Scientific
  • Mitricares Sas
  • Symetis SA
  • MORE

Report Scope:

Transcatheter treatment includes procedure types such as TAVR, TAVI, TMVR, and TMVI. Transcatheter procedure approaches include transfemoral, transapical and transaortic procedures. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for transcatheter treatment for heart valve diseases.

The format of this study includes the following:

  • Detailed description, including demographics and cost burden, of heart valve diseases (e.g., valvular stenosis and regurgitation) and transcatheter procedure approaches (e.g., transfemoral, transapical and transaortic.)
  • Detailed description and analysis of transcatheter treatments devices including TAVR, TAVI, TMVR, and TMVI devices.
  • Market characterization, unmet need, market size, and segmentation (by region and treatment).
  • Market drivers and restraints.
  • Detailed market projections through 2023.
  • Competition and market shares.
  • Key marketed and pipeline (R&D) products along with information about their regulatory status.
  • Strategic landscape (mergers and acquisitions).
  • Regulatory structure.
  • Pricing and reimbursement.
  • Observations and conclusions on the future of transcatheter treatment.
  • Profiles of market participants and associations.

The Report Includes:

  • 28 data tables and 25 additional tables
  • An overview of the global market for transcatheter treatment technologies
  • Analyses of global market trends, with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Analyses of the market by procedure segments, treatment approaches, and by region
  • Detailed market sizing and analyses of the various transcatheter devices and technologies in use or under development
  • Description of qualitative and quantitative factors that are driving the global market
  • Description of key marketed and pipeline devices and technologies
  • Profiles of major companies of the industry including, Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., Vascular Innovations Co. Ltd. and Valcare Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardiopolymers Inc.
  • Hormone Foundation
  • Microport Scientific
  • Mitricares Sas
  • Symetis SA
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Structural Heart Valve Disease

  • Structural Heart Disease
  • Spectrum of Structural Heart Disease
  • Valvular Heart Disease
  • Symptoms and Risk Factors of Structural Heart Disease
  • Causes of Structural Heart Disease
  • Rheumatic Fever
  • Mitral Valve Prolapse
  • Peripheral Artery Disease
  • Cardiovascular Disease
  • Aortic Aneurysm
  • Obesity
  • Diagnosis of Structural Heart Disease
  • Treatment of Structural Heart Disease
  • Management Through Medication
  • Surgical Intervention: Heart Valve Repair and Replacement
  • Tobacco Smoking and Heart Disease
  • Aging, Gender, and Structural Heart Diseases
  • Global Demographics
  • U.S. Demographics
  • European Demographics
  • Japanese Demographics
  • Current Challenges and Future Directions

Chapter 4 Aortic Valve Disease

  • Disease Overview
  • Types of Aortic Stenosis
  • Acquired Aortic Stenosis
  • Congenital Aortic Stenosis
  • Mild and Moderate Aortic Stenosis
  • Severe Aortic Stenosis
  • Asymptomatic Aortic Stenosis
  • Symptomatic Aortic Stenosis
  • Causes, Risk Factors, and Symptoms
  • Causes
  • Symptoms
  • Risk Factors
  • Epidemiology and Economic Burden
  • Diagnosis
  • Standard Doppler Echocardiography
  • Multimodality Imaging
  • Other Techniques
  • Treatment
  • Open Surgical Treatment (SAVR)
  • Transcatheter Treatment (TAVR/TAVI)
  • Aortic Valve Repair Versus Aortic Valve Replacement
  • Types of Transcatheter Approaches
  • Open Surgical Repair (SAVR) Versus Transcatheter Treatment (TAVR/TAVI)
  • TAVR and TAVI Complications
  • Key Marketed and Pipeline Products
  • Key Marketed Products
  • Key Pipeline/R&D Products
  • Self-expandable Versus Balloon-expandable Devices
  • Unmet Need
  • Current Challenges and Future Developments

Chapter 5 Mitral Valve Disease

  • Disease Overview
  • Types of Mitral Regurgitation
  • Degenerative Mitral Regurgitation
  • Functional Mitral Regurgitation
  • Mild and Moderate Mitral Stenosis
  • Severe Mitral Stenosis
  • Asymptomatic Mitral Stenosis
  • Symptomatic Mitral Stenosis
  • Causes, Risk Factors, and Symptoms
  • Causes
  • Symptoms
  • Risk Factors
  • Epidemiology and Economic Burden
  • Diagnosis
  • Standard Echocardiography
  • Multimodality Imaging
  • Other Techniques
  • Treatment
  • Open Surgical Treatment (SMVR)
  • Transcatheter Treatment (TMVR and TMVI)
  • Mitral Valve Repair Versus Mitral Valve Replacement
  • Types of Transcatheter Approaches
  • Open Surgery (SMVR) Versus Transcatheter Treatment (TMVR/TMVI)
  • TMVR Complications
  • Key Marketed and Pipeline Products
  • Key Marketed Products
  • Key Pipeline/R&D Products
  • Other Less Invasive (MIS) Mitral Valve Technologies
  • Unmet Need
  • Current Challenges and Future Developments

Chapter 6 Market Size and Growth Analysis

  • Market Size and Growth Analysis
  • Market Size and Growth Analysis, by Region
  • Market Size and Growth Analysis, by Segment
  • Market Size and Growth Analysis, by Procedure Approach
  • Market Size and Growth Analysis, by Procedure (TAVR/TAVI and TMVR)
  • Heart Valve Market: Traditional Heart Valves (Tissue Heart Valves and Mechanical Heart Valves) Versus Transcatheter Heart Valves
  • Market Growth Drivers and Restraints
  • Market Growth Drivers
  • Market Restraints

Chapter 7 Competitive Landscape in Transcatheter Treatment Devices Market

  • Competitive Landscape in Transcatheter Treatment Devices Market

Chapter 8 Market Strategies in the Transcatheter Treatment Devices Market

  • Market Consolidation in Cardiovascular Devices Market
  • Mergers and Acquisitions in Transcatheter Treatment Devices Market
  • Recent Mergers and Acquisitions
  • Venus Medtech Acquired Intervalve Inc.
  • LivaNova PLC Acquired Caisson Interventional LLC
  • Boston Scientific Acquired Symetis SA
  • Boston Scientific Acquired Neovasc’s Advanced Biological Tissue Manufacturing Assets along with a 15% Stake in Neovasc Inc.
  • Edwards Lifesciences Acquired Valtech Cardio Ltd.
  • Venus Medtech Inc. Acquired Transcatheter Technologies’ Technology Portfolio
  • Medtronic Acquired Twelve Inc.
  • Abbott Acquired Tendyne Holdings
  • Edwards Lifesciences Acquired CardiAQ Valve Technologies Inc.
  • Micro Interventional Devices Acquired Endovalve Inc.
  • Boston Scientific Acquired Sadra Medical Inc.
  • LoneStar Heart Acquired Cardiopolymers Inc.
  • Abbott Laboratories Acquired Evalve Inc.
  • Medtronic Acquired Ventor Technologies Ltd.
  • The Bracco Group acquired Heart Leaflet Technologies Inc. (HLT)
  • Minority Stakes and Future Options to Acquire
  • Abbott Laboratories Secures an Option to Buy Cephea Valve Technologies Inc.
  • Sorin Acquired Minority Stake in HighLife SAS
  • Boston Scientific Secures an Option to Buy MValve Technologies Ltd.
  • Sorin Group Acquired Minority Stake in Cardiosolutions Inc.
  • Future Strategic Landscape

Chapter 9 Regulatory Structure: Medical Devices

  • Regulatory Background
  • Regulatory Systems for Medical Devices, by Region
  • U.S.
  • European Union (EU)
  • Japan

Chapter 10 Pricing and Reimbursement: Medical Devices

  • Pricing and Reimbursement Background
  • Pricing and Reimbursement for Medical Devices, by Region
  • U.S.
  • Europe
  • Japan

Chapter 11 Conclusions-Outlook for Transcatheter Treatment Devices

  • Major Developments Influencing the Market
  • Technological Developments
  • Demographic and Economic Trends
  • Changing Structure of the Healthcare Industry
  • Long-term Outlook for Transcatheter Treatments

Chapter 12 Company Profiles

  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corp.
  • Bracco Spa
  • Braile Biomédica
  • Cardiac Dimensions Inc.
  • Cephea Valve Technologies Inc.
  • Colibri Heart Valve Llc
  • Direct Flow Medical Inc.
  • Edwards Lifesciences Corp.
  • Gorman Cardiovascular Research Group
  • Hansen Medical Inc. (Subsidiary Of Auris Health Inc.)
  • Highlife Sas
  • Jenavalve Technology Inc.
  • Laboratories Invalv
  • Livanova Plc
  • Lonestar Heart Inc.
  • Medtronic Inc.
  • Micro Interventional Devices Inc.
  • Microport Scientific
  • Mitragen Inc.
  • Mitralix Ltd.
  • Mitraltech Ltd.
  • Mitrassist Ltd.
  • Mitricares Sas
  • Mitral Heal Ltd.
  • Mitralign Inc.
  • MVRX Inc.
  • Nakostech Sarl
  • Navigate Cardiac Structures Inc.
  • Neovasc Inc.
  • New Valve Technology (Nvt) Ag
  • Sino Medical Science Technology Inc.
  • St. Jude Medical Inc. (Subsidiary Of Abbott Laboratories)
  • TAU-PNU Medical Co. Ltd.
  • Thubrikar Aortic Valve Inc.
  • Transcatheter Technologies Gmbh
  • Transmural Systems
  • Vascular Innovations Co. Ltd.
  • Valcare Inc.
  • Valvexchange Inc.
  • Venus Medtech Inc.

Chapter 13 Appendix A: List of Acronyms

Chapter 14 Appendix B: Professional Organizations

  • American Heart Association
  • Center for Drug Evaluation and Research (CDER)
  • Center for Devices and Radiological Health (CDRH)
  • Centers for Medicare & Medicaid Services (CMS)
  • European Databank for Medical Devices (EUDAMED)
  • Food and Drug Administration (FDA or USFDA)
  • Hormone Foundation
  • International Diabetes Federation (IDF)
  • International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
  • Network for Excellence in Health Innovation (NEHI)
  • National Center for Biotechnology Information (NCBI)
  • National Institute of Aging (NIA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • World Cancer Research Fund International
  • World Health Organization (WHO)

List of Tables
Summary Table: Global Market for Transcatheter Treatment Devices, by Region, Through 2023
Table 1: Scope of Structural Heart Diseases
Table 2: Leading Peripheral Vascular Disease Conditions
Table 3: Global Prevalence of Peripheral Artery Disease, Through 2021
Table 4: Global Incidence Share of Hypertension, by Patient Group, 2017
Table 5: Global Prevalence of Angina Pectoris and Stroke, by Survivors, Through 2030
Table 6: Global Prevalence of Congestive Heart Failure and Stroke, by Type, Through 2030
Table 7: Epidemiology, AAA vs. TAA
Table 8: Global vs. U.S. Prevalence of AAA, Through 2023
Table 9: BMI Calculation
Table 10: BMI Categories Based on Increasing Health Risks
Table 11: Trends in Obesity in the World’s Population, by Segment, Through 2021
Table 12: U.S. Obesity and Severe Obesity vs. General Population, by Segment, Through 2021
Table 13: Structural Heart Disease, Management Through Medication
Table 14: Structural Heart Valve Disease Treatment Through Surgical Intervention
Table 15: Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 16: World Population, by Region, Through 2030
Table 17: U.S. Population Estimates and Projections, by Age Group, Through 2030
Table 18: Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
Table 19: European Population Estimates and Projections, by Age Group, Through 2030
Table 20: Japanese Population Estimates and Projections, by Age Group, Through 2030
Table 21: Aortic Valve Area and Calcification Score, by Stage of Aortic Stenosis
Table 22: Global vs. U.S. Prevalence of Aortic Stenosis, Through 2023
Table 23: Global vs. U.S. Prevalence of Severe/Symptomatic Aortic Stenosis, Through 2023
Table 24: Imaging Techniques for Aortic Stenosis Diagnosis
Table 25: Types of Aortic Valve and Repair Techniques
Table 26: Advantages and Challenges of TAVI vs. TAVR
Table 27: TAVR Access Routes for Aortic Stenosis
Table 28: Key Marketed Products in Transcatheter Aortic Valve Treatment
Table 29: Key Pipeline/R&D Products in Transcatheter Aortic Valve Treatment
Table 30: Mitral Valve Area, by Stage of Mitral Stenosis
Table 31: Global vs. U.S. Prevalence of Mitral Regurgitation, Through 2023
Table 32: Global vs. U.S. Prevalence of Severe/Symptomatic Mitral Regurgitation, Through 2023
Table 33: Imaging Techniques for the Diagnosis of Mitral Valve Disease
Table 34: Types of Mitral Valve Repair
Table 35: Types of Mitral Valve and Repair Techniques
Table 36: TMVI vs. TMVR, Advantages and Challenges
Table 37: Key Marketed Products, Transcatheter Mitral Valve Treatment
Table 38: Key Pipeline/R&D Products, Transcatheter Mitral Valve Treatment
Table 39: Transcatheter Mitral Valve Treatment, Other Less Invasive (MIS) Mitral Valve Technologies
Table 40: Global Market for Transcatheter Treatment Devices, by Region, Through 2023
Table 41: Global Market for Transcatheter Treatment Devices, by Segment, Through 2023
Table 42: Global Market for Transcatheter Treatments, by Procedure (TAVR/TAVI and TMVR), Through 2023
Table 43: Global Market for Heart Valves, by Type of Valve, Through 2023
Table 44: Global Market for Transcatheter Treatment Devices, by Leading Company, 2017
Table 45: Key Strategic Deals in Transcatheter Treatments Market, 2008-2017
Table 46: Other Key Strategic Deals (Minority Stakes and Future Options to Acquire) in Transcatheter Treatments Market, 2012-2015
Table 47: Differences in Regulatory Approval in the U.S. and Europe
Table 48: Transcatheter Aortic Valve Procedures, Billing and Reimbursement, U.S.
Table 49: Operations on Aortic Valve, ICD-10 Procedure Code
Table 50: Hospital Inpatient Procedures Utilizing MS-DRGs, National Average Reimbursement, CMS
Table 51: Trends in Per Capita Real GDP Growth, by Region, 2014-2017
Table 52: List of Acronyms

List of Figures
Summary Figure: Global Market for Transcatheter Treatment Devices, by Region, 2017-2023
Figure 1: Global Prevalence of Peripheral Artery Disease, 2000-2021
Figure 2: Global Incidence Share of Hypertension, by Patient Group, 2017
Figure 3: Global Prevalence of Angina Pectoris and Stroke, by Survivors, 2004-2030
Figure 4: Global Prevalence of Congestive Heart Failure and Stroke, by Type, 2004-2030
Figure 5: Global vs. U.S. Prevalence of AAA, 2017-2023
Figure 6: Trends in Obesity in the World’s Population, by Segment, 2012-2021
Figure 7: U.S. Obesity and Severe Obesity vs. General Population, by Segment, 2016 and 2021
Figure 8: Estimated World Population and Annual Growth, by Selected Age Group, 2000-2030
Figure 9: World Population, by Selected Region, 2000-2030
Figure 10: U.S. Population Estimates and Projections, by Age Group, 2000-2030
Figure 11: Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
Figure 12: European Population Estimates and Projections, by Age Group, 2000-2030
Figure 13: Japanese Population Estimates and Projections, by Age Group, 2000-2030
Figure 14: Global vs. U.S. Prevalence of Aortic Stenosis, 2017-2023
Figure 15: Global vs. U.S. Prevalence of Severe/Symptomatic Aortic Stenosis, 2017-2023
Figure 16: Global vs. U.S. Prevalence of Mitral Regurgitation, 2017-2023
Figure 17: Global vs. U.S. Prevalence of Severe/Symptomatic Mitral Regurgitation, 2017-2023
Figure 18: Global Market for Transcatheter Treatment Devices, by Region, 2017-2023
Figure 19: Global Market for Transcatheter Treatment Devices, by Segment, 2017-2023
Figure 20: Global Market Share for Transcatheter Mitral Valve Repair, by Disease Condition, 2017
Figure 21: Global Market Share for Transcatheter Treatment Devices, by Valve Type, 2017
Figure 22: Global Market Share for Transcatheter Aortic Valve Repair Market, by Procedure Approach, 2017
Figure 23: Global Market for Transcatheter Treatments, by Procedure (TAVR/TAVI and TMVR), 2017-2023
Figure 24: Global Market for Heart Valves, by Type of Valve, 2017-2023
Figure 25: Global Heart Valve Repair Market Share, by Surgery Type, 2017
Figure 26: Global Market Share for Transcatheter Treatment Devices, by Leading Company, 2017
Figure 27: Trends in Per Capita Real GDP Growth, by Region, 2014-2017

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardiopolymers Inc.
  • Hormone Foundation
  • Microport Scientific
  • Mitricares Sas
  • Symetis SA
  • MORE

Regionally, the U.S. is expected to maintain dominance in the global market of transcatheter treatment devices. Those wishing to invest in the transcatheter treatment devices market ought to strongly consider high-growth areas such as transcatheter aortic valve repair (TAVR), transcatheter mitral valve implantation (TMVI), and transcatheter mitral valve repair (TMVR) devices and technologies. The market is growing primarily due to the growing geriatric population, increasing the prevalence of chronic diseases, continuous technological advancements, increasing adoption of transcatheter techniques, and positive reimbursement and other healthcare reforms.

Note: Product cover images may vary from those shown
5 of 6
  • Abbott Laboratories
  • American Heart Association
  • Biotronik
  • Boston Scientific Corp.
  • Bracco SPA
  • Braile Biomédica
  • Caisson Interventional LLC
  • Cardiac Dimensions Inc.
  • Cardiac Structures Inc.
  • CardiAQ Valve Technologies Inc.
  • Cardiopolymers Inc.
  • Cardiosolutions Inc.
  • Center for Devices and Radiological Health (CDRH)
  • Center for Drug Evaluation and Research (CDER)
  • Centers for Medicare & Medicaid Services (CMS)
  • Cephea Valve Technologies Inc.
  • Colibri Heart Valve Llc
  • Direct Flow Medical Inc.
  • Edwards Lifesciences Corp.
  • Endovalve Inc.
  • European Databank for Medical Devices (EUDAMED)
  • Evalve Inc.
  • Food and Drug Administration (FDA or USFDA)
  • Gorman Cardiovascular Research Group
  • Hansen Medical Inc. (Subsidiary Of Auris Health Inc.)
  • Heart Leaflet Technologies Inc. (HLT)
  • HighLife SAS
  • Hormone Foundation
  • International Diabetes Federation (IDF)
  • International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
  • Intervalve Inc.
  • Jenavalve Technology Inc.
  • Laboratories Invalv
  • LivaNova PLC
  • Lonestar Heart Inc.
  • Medtronic Inc.
  • Micro Interventional Devices Inc.
  • Microport Scientific
  • Mitragen Inc.
  • Mitral Heal Ltd.
  • Mitralign Inc.
  • Mitralix Ltd.
  • Mitraltech Ltd.
  • Mitrassist Ltd.
  • Mitricares Sas
  • MValve Technologies Ltd.
  • MVRX Inc.
  • Nakostech Sarl
  • National Center for Biotechnology Information (NCBI)
  • National Institute of Aging (NIA)
  • Neovasc Inc.
  • Network for Excellence in Health Innovation (NEHI)
  • New Valve Technology (Nvt) Ag
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • Sadra Medical Inc.
  • Sino Medical Science Technology Inc.
  • Sorin Group
  • St. Jude Medical Inc. (Subsidiary Of Abbott Laboratories)
  • Symetis SA
  • TAU-PNU Medical Co. Ltd.
  • Tendyne Holdings
  • The Bracco Group
  • Thubrikar Aortic Valve Inc.
  • Transcatheter Technologies Gmbh
  • Transmural Systems
  • Twelve Inc.
  • Valcare Inc.
  • Valtech Cardio Ltd.
  • Valvexchange Inc.
  • Vascular Innovations Co. Ltd.
  • Ventor Technologies Ltd.
  • Venus Medtech Inc.
  • World Cancer Research Fund International
  • World Health Organization (WHO)
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4750821
Adroll
adroll